Table 2 Treatment exposure (FAS)
|  | PHN (n = 89) | HIV-AN (n = 5) | NBP (n = 50) | CRNP (n = 22) | PONP (n = 198) | Other (n = 56) | Overall (n = 420) |
|---|---|---|---|---|---|---|---|
Patients treated at each application, n (%) | |||||||
 First treatment | 89 (21.2) | 5 (1.2) | 50 (11.9) | 22 (5.2) | 198 (47.1) | 56 (13.3) | 420 (100) |
 Second treatment | 40 (9.5) | 2 (0.5) | 15 (3.6) | 8 (1.9) | 97 (23.1) | 19 (4.5) | 181 (43.1) |
 Third treatment | 16 (3.8) | – | 4 (1.0) | 4 (1.0) | 38 (9.0) | 8 (1.9) | 70 (16.7) |
Mean size of treatment area, cm2 (SD) | |||||||
 First treatment | 298.6 (168.1) | 380.0 (138.6) | 297.7 (196.9) | 519.5 (404.9) | 271.5 (209.7) | 362.0 (263.9) | 306.4 (228.2) |
 Second treatment | 286.8 (169.3) | 210.0 (99.0) | 291.3 (160.6) | 566.6 (387.9) | 278.6 (206.4) | 391.5 (300.5) | 306.4 (225.0) |
 Third treatment | 270.0 (190.6) | – | 357.5 (230.7) | 467.5 (113.5) | 229.7 (211.8) | 487.4 (412.4) | 294.8 (248.8) |
Mean number of patches (SD) | |||||||
 First treatment | 1.4 (0.6) | 1.4 (0.6) | 1.3 (0.6) | 2.1 (1.3) | 1.4 (0.7) | 1.6 (0.8) | 1.5 (0.7) |
 Second treatment | 1.4 (0.6) | 1.0 (0.0) | 1.4 (0.6) | 2.3 (1.2) | 1.5 (0.7) | 1.7 (0.9) | 1.5 (0.7) |
 Third treatment | 1.4 (0.7) | – | 1.8 (1.0) | 2.0 (0.0) | 1.4 (0.8) | 2.0 (1.3) | 1.6 (0.8) |
Patients completing ≥90% of recommended treatment durationa, n (%) | |||||||
 First treatment | 84 (94.4) | 5 (100) | 47 (94.0) | 19 (86.4) | 184 (93.9) | 49 (87.5) | 388 (92.8) |
 Second treatment | 37 (94.9) | 2 (100) | 12 (85.7) | 7 (87.5) | 81 (94.2) | 18 (100) | 157 (94.0) |
 Third treatment | 16 (100) | – | 4 (100) | 4 (100) | 33 (100) | 7 (87.5) | 63 (98.4) |